After decades of decline, rates of cervical cancer within Canada have plateaued, according to the Canadian Cancer Society — a ...

Nuvalent has reported phase 1/2 lung cancer data, teeing the biotech up to talk to the FDA about an approval filing that could establish its neladalkib as a challenger to Pfizer’s Lorbrena.

American Cancer Society researchers stress improving awareness of lung cancer screening is needed to help save lives ...

A clinical oncology research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with ...

The GA4GH is uniting researchers worldwide to share genomic data responsibly, set open standards, and improve oncology care ...

Under Trump policies, cancer registries in 2026 will have to classify sex data strictly as male, female, or unknown, a change ...

Source: Getty Images Breast cancer is the second most common cancer affecting American women and the second leading cause of cancer death in women. These numbers are higher than estimates from 2023, ...

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) use was significantly associated with a reduced odds of five-year mortality, but this protective effect was found to be statistically significant ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endometrial cancer. The biotech reported a 50% unconfirmed response rate, beating the expectations of William Blair ...

As recognized leaders in cancer research, Huntsman Cancer Institute physicians and scientists are utilizing artificial intelligence (AI) to accelerate discoveries and improve patient care. When I was ...

“1 in 20 Iowans have had a diagnosis of cancer in their lifetime, and if the trends continue, we’re headed towards one in 10.” Dr. Mary Charlton, Director of the Iowa Cancer Registry SIOUX CITY (KTIV) ...